CO.DON AG Share · DE000A1K0227 · A1K022 (XFRA) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of CO.DON AG
No Price
Company Profile for CO.DON AG Share
co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage and spinal disc defects worldwide. The company develops, produces, and markets autologous cell therapies for the minimally invasive repair of cartilage damage to knee joints following traumatic or degenerative defects. Its therapies include matrix-associated autologous cartilage transplantation, a biological therapy for the treatment of damaged articular cartilage with the body's own cells; and autologous chondrocyte transplantation for the regeneration of biomechanical load-bearing and pressure-resistant cartilage tissue. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
Company Data
Name CO.DON AG
Company co.don AG
Website
http://www.codon.de
Primary Exchange 
Frankfurt
Frankfurt
WKN A1K022
ISIN DE000A1K0227
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dipl.-Kfm. Dirk Hessel
Country Germany
Currency EUR
Employees 0,1 T
Address Warthestrasse 21, Teltow
IPO Date 2001-02-01
Stock Splits
| Date | Split |
|---|---|
| 19.08.2021 | 1:2 |
Ticker Symbols
| Name | Symbol |
|---|---|
| XETRA | CNWK.DE |
More Shares
Investors who hold CO.DON AG also have the following shares in their portfolio:
